„FX“
Suchergebnisse
1.000+ Treffer
-
Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis
-
Characterization, treatment patterns, and patient-related outcomes of patients with Fragile X syndrome in Germany: final results of the observational EXPLAIN-FXS study
-
Genome-wide analysis of hepatic LRH-1 reveals a promoter binding preference and suggests a role in regulating genes of lipid metabolism in concert with FXR
-
Abnormal Scn1b and Fxyd1 gene expression in the pulled-through ganglionic colon may influence functional outcome in patients with Hirschsprung’s disease
-
Carriage of One or Two FMR1 Premutation Alleles Seems to Have No Effect on Illness Severity in a FXTAS Female with an Autozygous FMR1 Premutation Allele
-
Update on the Clinical, Radiographic, and Neurobehavioral Manifestations in FXTAS and FMR1 Premutation Carriers
-
FXYD6: a novel therapeutic target toward hepatocellular carcinoma
-
FXR1 is elevated in colorectal cancer and acts as an oncogene
-
A Majority of FXTAS Cases Present with Intranuclear Inclusions Within Purkinje Cells
-
Change in the Behavioral Phenotype of Adolescents and Adults with FXS: Role of the Family Environment
-
MiRNA-145 Regulates the Development of Congenital Heart Disease Through Targeting FXN
-
A novel minimally invasive and press-fit method for symphysiodesis - a biomechanical analysis
-
Front Cover: Activation and Identification of NC‐1: A Cryptic Cyclodepsipeptide from Red Soil‐Derived Streptomyces sp. FXJ1.172 (Eur. J. Org. Chem. 23/2016)
-
Plasminogen activator inhibitor-1 (PAI-1), toll-like receptor 4 (TLR4), factor II (FII), FXIII and fibrinogen polymorphisms are not associated with the prevalence of sudden death due to ventricular fibrillation during myocardial infarction
-
Front Cover: When Two Become One: Conformational Changes in FXR/RXR Heterodimers Bound to Steroidal Antagonists (ChemMedChem 4/2023)
-
Cover Feature: Microscale Parallel Synthesis of Acylated Aminotriazoles Enabling the Development of Factor XIIa and Thrombin Inhibitors (ChemMedChem 24/2021)
-
Syntheses and Characterizations of the Mixed Noble‐Gas Compounds, [FKr II FXe II F][AsF 6 ]⋅0.5 Kr II F 2 ⋅2 HF, ([Kr II 2 F 3 ][AsF 6 ]) 2 ⋅Xe IV F 4 , and Xe IV F 4 ⋅Kr II F 2
-
Syntheses and Characterizations of the Mixed Noble‐Gas Compounds, [FKr II FXe II F][AsF 6 ]⋅0.5 Kr II F 2 ⋅2 HF, ([Kr II 2 F 3 ][AsF 6 ]) 2 ⋅Xe IV F 4 , and Xe IV F 4 ⋅Kr II F 2
-
Front Cover: Development of Selective TGR5 Ligands Based on the 5,6,7,8‐Tetrahydro‐5,5,8,8‐tetramethylnaphthalene Skeleton (ChemMedChem 3/2021)
-
Development of Novel High-Resolution Melting-Based Assays for Genotyping Two Alu Insertion Polymorphisms (FXIIIB and PV92)